Advertisement

Pfizer-Medivation buyout News

alt
Pfizer Inc, beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company`s growing oncology roster.






Loading...
english news
NEWS ON ONE CLICK